U.S. federal trademark · Serial No. 85481793 · Reg. No. 4377197
Research, and development of new and generic pharmaceutical products, including delivery systems such as controlled release formulations, and systems that include the use of nanoparticles, transdermal, microencapsulation, and polymeric oral delivery systems
Custom manufacturing in the field of new and generic pharmaceutical products, including delivery systems such as controlled release formulations, and systems that include the use of nanoparticles, transdermal, microencapsulation, and polymeric oral delivery systems
Commercialization, namely, commercial feasibility studies in the field of new and generic pharmaceutical products, including delivery systems such as controlled release formulations, and systems that include the use of nanoparticles, transdermal, microencapsulation, and polymeric oral delivery systems
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.